AU4501199A - 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors - Google Patents

8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors

Info

Publication number
AU4501199A
AU4501199A AU45011/99A AU4501199A AU4501199A AU 4501199 A AU4501199 A AU 4501199A AU 45011/99 A AU45011/99 A AU 45011/99A AU 4501199 A AU4501199 A AU 4501199A AU 4501199 A AU4501199 A AU 4501199A
Authority
AU
Australia
Prior art keywords
phosphodiesterase inhibitors
phenylxanthine
derivatives
phenylxanthine derivatives
phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45011/99A
Inventor
Joan Feixas Gras
Jordi Gracia Ferrer
Jose Manuel Prieto Soto
Armando Vega Noverola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma SA filed Critical Almirall Prodesfarma SA
Publication of AU4501199A publication Critical patent/AU4501199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
AU45011/99A 1998-06-03 1999-05-26 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors Abandoned AU4501199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES9801152 1998-06-03
ES9801152 1998-06-03
PCT/EP1999/003644 WO1999062905A1 (en) 1998-06-03 1999-05-26 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors

Publications (1)

Publication Number Publication Date
AU4501199A true AU4501199A (en) 1999-12-20

Family

ID=8304000

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45011/99A Abandoned AU4501199A (en) 1998-06-03 1999-05-26 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors

Country Status (5)

Country Link
AR (1) AR018619A1 (en)
AU (1) AU4501199A (en)
CO (1) CO5021199A1 (en)
PE (1) PE20000557A1 (en)
WO (1) WO1999062905A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU777571B2 (en) * 1999-07-27 2004-10-21 Almirall Prodesfarma S.A. 8-phenyl-6,9-dihydro-(1,2,4)triazolo(3,4-i)purin-5-one derivatives

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007934D0 (en) * 2000-03-31 2000-05-17 Darwin Discovery Ltd Chemical compounds
US6919337B2 (en) 2000-04-07 2005-07-19 Novartis, Ag 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
GB0008694D0 (en) * 2000-04-07 2000-05-31 Novartis Ag Organic compounds
US7019136B2 (en) 2000-04-07 2006-03-28 Novartis, Ag 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
JP2003535864A (en) * 2000-06-07 2003-12-02 アルミラル プロデスファルマ ソシエダ アノニマ 6-Phenylpyrrolopyrimidinedione derivative
AU2001289782A1 (en) 2000-08-09 2002-02-18 Almirall Prodesfarma, S.A. Pyrrolotriazolopyrimidinone derivatives
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
CN1127506C (en) * 2001-06-29 2003-11-12 刘宝顺 Compound for treating impotence
JP4450365B2 (en) 2001-08-28 2010-04-14 シェーリング コーポレイション Polycyclic guanine phosphodiesterase V inhibitor
CN1585771A (en) 2001-11-09 2005-02-23 先灵公司 Polycyclic guanine derivative phosphodiesterase V inhibitors
EP3749697A4 (en) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347290A1 (en) * 1983-12-28 1985-07-11 Dr. Karl Thomae Gmbh, 7950 Biberach NEW 2-PHENYL IMIDAZOLES, THEIR PRODUCTION AND MEDICINES CONTAINING THESE COMPOUNDS
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU777571B2 (en) * 1999-07-27 2004-10-21 Almirall Prodesfarma S.A. 8-phenyl-6,9-dihydro-(1,2,4)triazolo(3,4-i)purin-5-one derivatives

Also Published As

Publication number Publication date
AR018619A1 (en) 2001-11-28
CO5021199A1 (en) 2001-03-27
PE20000557A1 (en) 2000-07-20
WO1999062905A1 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
IL141445A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
AU4791797A (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
AU3034300A (en) Substituted benzimidazoles and their use as parp inhibitors
HUP0103349A3 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
AU5759999A (en) Pyrimidone derivatives
SI1475377T1 (en) Derivatives of indole and their use as phosphodiesterase 4 inhibitors
AU2001240542A1 (en) Heterocyclic compounds and their use as parp inhibitors
AU6230098A (en) Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2002227985A1 (en) Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
PL337645A1 (en) Novel amidine derivatives and their application as thrombosin inhibitors
AU2274299A (en) Benzazine derivatives phosphodiesterase 4 inhibitors
HK1039124B (en) Phthalzaine derivatives phosphodiesterase 4 inhibitors
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
IL141446A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU2002366736A1 (en) Masked phosphate containing nucleoside derivatives and their use as antivirals
AU4268796A (en) Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
PL361733A1 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
AU1766997A (en) Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
AU2002216650A1 (en) Triazine derivatives as lpaat-b inhibitors and uses thereof
AU5050198A (en) Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
HK1066804A1 (en) Derivatives of indole and their use as phosphodiesterase 4 inhibitors
AU2001266124A1 (en) 2-aminothiazoline derivatives and their use as no-synthase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase